🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, multicenter, phase 1b/2 trial of IMM01 (SIRPα Fc) pl...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2022-05-17
Trial ID
NCT05833984
Treatments Being Tested
This trial is an open-lable , multi-center, Phase 1/Phase 2 study that will...
Status
Unknown
Location
Beijing gobroad boren hospital
Start Date
2022-01-05
Trial ID
NCT05140811
Treatments Being Tested
This is a Phase 1, open-label, dose-escalation and cohort expansion study d...
Status
Not Yet Recruiting
Location
Shanghai Gobroad Cancer Hospital China Pharmaceutical University
Start Date
2025-10-15
Trial ID
NCT07170787
Placebo controlled study for safety and efficacy of IMM01-STEM on muscle pe...
Status
Active Not Recruiting
Location
National Institute of Clinical Research (NICR)
Start Date
2024-12-19
Trial ID
NCT06600581
Treatments Being Tested
An open-label dose escalation study to assess the safety and tolerability o...
Status
Recruiting
Location
Orthopaedic Specialty Institute
Start Date
2022-09-13
Trial ID
NCT05211986
Treatments Being Tested
This study is a randomized, controlled, double-blind, multicenter, phase Ⅲ ...
Status
Recruiting
Location
Anhui Provincial Hospital
Start Date
2024-11-11
Trial ID
NCT06647862
Treatments Being Tested
The expanded access is designed for patients requesting the treatment, and ...
Status
Temporarily Not Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT06784297
Treatments Being Tested
The purpose of this study is to compare efficacy of IMM01 plus Tiselizumab ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-06
Trial ID
NCT06465446
Treatments Being Tested
This is a Phase 2, open-label, multicenter,study designed to evaluate the s...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-23
Trial ID
NCT07687914
Treatments Being Tested
This is a multi-center, open-label, dose-escalation and cohort-expansion ph...
Status
Terminated
Location
Chinese Academy of Medical Sciences and Peking Union Medical College,
Start Date
2019-11-19
Trial ID
NCT05860075
Treatments Being Tested